Cost-effectiveness of ultrasound-guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial

E Tassie; G Scotland; J Brittenden; SC Cotton; A Elders; MK Campbell; B Campbell; M Gough; JM Burr; CR Ramsay; J Cruden; T Davidson; J Francis; A McDonald; G McPherson; S Wileman; I Chetter; JJ Earnshaw; T Lees; J Scott; S Baker; G MacLennan; M Prior; D Bolsover; J Wallace; E Wilson; S Hardy; K Hargreaves; D Rittoo; S Baker; N Park; D Parker; J Hatfield; J Scott; N Dewhirs; N Parr; D Dodd; J Sorrell; KR Makhdoomi; B Rorison; I Nyamekye; P Matheson

Journal article

Cost-effectiveness of ultrasound-guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial

E Tassie, G Scotland, J Brittenden, SC Cotton, A Elders, MK Campbell, B Campbell, M Gough, JM Burr, CR Ramsay, J Cruden, T Davidson, J Francis, A McDonald, G McPherson, S Wileman, I Chetter, JJ Earnshaw, T Lees, J Scott Show all

British Journal of Surgery | WILEY | Published : 2014

DOI: 10.1002/bjs.9595

Abstract

Background: The treatment of patients with varicose veins constitutes a considerable workload and financial burden to the National Health Service. This study aimed to assess the cost-effectiveness of ultrasound-guided foam sclerotherapy (UGFS) and endovenous laser ablation (EVLA) compared with conventional surgery as treatment for primary varicose veins.Methods: Participant cost and utility data were collected alongside the UK CLASS multicentre randomized clinical trial, which compared EVLA, surgery and UGFS. Regression methods were used to estimate the effects of the alternative treatments on costs to the health service and quality-adjusted life-years (QALYs) at 6 months. A Markov model, in..

View full abstract

University of Melbourne Researchers

Jill Francis Author

Grants

Awarded by National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme

Awarded by Chief Scientist Office

Awarded by National Institute for Health Research

Funding Acknowledgements

This work was carried out as part of a project funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme (project number 06/45/02). The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the NIHRHTA Programme, NIHR, NHS or Department of Health.